X 3 2 (Amoxicillin and Clavulanate Potassium 875 mg / 125 mg)
Pill with imprint X 3 2 is White, Capsule-shape and has been identified as Amoxicillin and Clavulanate Potassium 875 mg / 125 mg. It is supplied by Aurobindo Pharma Limited.
Amoxicillin/clavulanate is used in the treatment of bacterial infection; bronchitis; aspiration pneumonia; bronchiectasis; febrile neutropenia and belongs to the drug class beta-lactamase inhibitors. There is no proven risk in humans during pregnancy. Amoxicillin/clavulanate 875 mg / 125 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for X 3 2
Amoxicillin and Clavulanate Potassium
- Imprint
- X 3 2
- Strength
- 875 mg / 125 mg
- Color
- White
- Size
- 22.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Beta-lactamase inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aurobindo Pharma Limited
- Inactive Ingredients
-
silicon dioxide,
crospovidone,
hypromellose 2910 (5 mPa.s),
hypromellose 2910 (15000 mPa.s),
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol 4000,
polyethylene glycol 6000,
sodium starch glycolate type A potato,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 65862-0503 | Aurobindo Pharma Limited |
| 16714-0297 | NorthStar Rx LLC |
Related images for "X 3 2"
More about amoxicillin / clavulanate
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (830)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: beta-lactamase inhibitors
Patient resources
- Drug Information
- Amoxicillin and clavulanate potassium
- Amoxicillin and clavulanate (Advanced Reading)
- Amoxicillin/Clavulanate Chewable Tablets
- Amoxicillin/Clavulanate Extended-Release Tablets
- Other brands
- Augmentin, Augmentin XR, Augmentin ES-600, Amoclan
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.